We report on the genetic and molecular characterisation of an Italian family with a late-onset, autosomal dominant transthyretin amyloidosis. The transthyretin gene was analysed by polymerase chain reaction (PCR), restriction generating PCR, and sequencing, allowing us to discover in one allele a novel point mutation. It consists of a G to C transversion at position 1692 of the genomic sequence, leading to a Thr for Arg substitution at the position 34 of the polypeptidic chain. This mutation is associated with a severe sensory-motor peripheral neuropathy and a restrictive cardiomyopathy
Two unrelated Italian families affected by hereditary amyloidosis are described. Molecular genetic c...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...
Familial amyloidotic polyneuropathy is a rare autosomal dominant disease, with clinical symptoms beg...
We report the biochemical and molecular characterization of two new transthyretin (TTR) variants in ...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
Transthyretin gene mutations are associated with autosomal dominant familial amyloidosis. The common...
Amyloidosis is a disorder of protein metabolism characterized by extracellular accumulation of abnor...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
A Dutch family with familial amyloidotic polyneuropathy associated with the transthyretin mutation V...
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
AbstractDNA sequence polymorphisms in transthyretin (TrR) genes were investigated by single-strand c...
We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu5...
Two unrelated Italian families affected by hereditary amyloidosis are described. Molecular genetic c...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...
Familial amyloidotic polyneuropathy is a rare autosomal dominant disease, with clinical symptoms beg...
We report the biochemical and molecular characterization of two new transthyretin (TTR) variants in ...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
Transthyretin gene mutations are associated with autosomal dominant familial amyloidosis. The common...
Amyloidosis is a disorder of protein metabolism characterized by extracellular accumulation of abnor...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
A Dutch family with familial amyloidotic polyneuropathy associated with the transthyretin mutation V...
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
AbstractDNA sequence polymorphisms in transthyretin (TrR) genes were investigated by single-strand c...
We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu5...
Two unrelated Italian families affected by hereditary amyloidosis are described. Molecular genetic c...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
Abstract Transthyretin (TTR)-related familial amyloid polyneuropathy (TTR-FAP) is a life-threatening...